Survey and systematic literature review of probiotics stocked in academic medical centers within the United States

Hospital Pharmacy

Volumn 48, Issue 10, 2013, Pages 834-847

  Abe, Andrew ^a   Gregory, Philip ^a   Hein, Darren ^a   Cochrane, Zara Risoldi ^a   Wilson, Amy ^a  

^a CREIGHTON UNIVERSITY   (United States)

Author keywords

academic medical centers; dietary supplements; health care survey; hospital formularies; probiotics

Indexed keywords

BACID; CULTURELLE; FLORA Q; FLORA Q2; FLORAJEN3; FLORANEX; FLORASTOR; LACTINEX; PLACEBO; PROBIOTIC 123; PROBIOTIC AGENT; UNCLASSIFIED DRUG; VSL3;

ANTIBIOTIC ASSOCIATED DIARRHEA; CLINICAL RESEARCH; HEALTH CARE SURVEY; HUMAN; MAJOR CLINICAL STUDY; NECROTIZING ENTEROCOLITIS; REVIEW; TELEPHONE INTERVIEW; UNITED STATES; UNIVERSITY HOSPITAL;

EID: 84887450713     PISSN: 00185787     EISSN: 19451253     Source Type: Journal    
DOI: 10.1310/hpj4810-834     Document Type: Review

References (31)

1. Hempel S, Newberry SJ, Maher AR. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: A systematic review and meta-analysis. JAMA. 2012;307(18): 1959-1969.
2. Gupta V, Garg R. Probiotics. Indian J Med Microbiol. 2009;27:202-209.
3. Todorov SD, Furtado DN, Saad SM, Gombossy de Melo Franco BD. Bacteriocin production and resistance to drugs are advantageous features for Lactobacillus acidophilus La-14, a potential probiotic strain. New Microbiol. 2011;34(4):357-370.
4. Oelschlaeger T. Mechanisms of probiotic actions-A review. Int J Med Microbiol. 2010;300(1):57-62.
5. Ohashi Y, Ushida K. Health-beneficial effects of probiotics: Its mode of action. Anim Sci J. 2009;80(4):361-371.
6. Van Tassell M, Miller M. Lactobacillus adhesion to mucus. Nutrients. 2011;3(5):613-636.
7. Higgins J, Altman D, Sterne J. Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. www.cochrane-handbook.org.
8. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics. 1991;88(1):90-97.
9. Shornikova AV, Isolauri E, Burkanova L, Lukovnikova S, Vesikari T. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea. Acta Paediatr. 1997;86(5):460-465.
10. Guandalini S, Pensabene L, Zikri MA, et al. Lactobacillus GG administered in oral rehydration solution to childrenwith acute diarrhea: A multicenter European trial. J Pediatr Gastroenterol Nutr. 2000;30(1):54-60.
11. Salazar-Lindo E,Miranda-Langschwager P, Campos-SanchezM, Chea-Woo E, Sack RB. Lactobacillus casei strain GG in the treatment of infants with acute watery diarrhea: A randomized, double-blind, placebo controlled clinical trial [ISRCTN67363048]. BMC Pediatr. 2004;4:18.
12. Basu S, Chatterjee M, Ganguly S, Chandra PK. Efficacy of Lactobacillus rhamnosus GG in acute watery diarrhoea of Indian children: A randomised controlled trial. J Paediatr Child Health. 2007;43(12):837-842.
13. Basu S, Paul DK, Ganguly S, Chatterjee M, Chandra PK. Efficacy of high-dose Lactobacillus rhamnosus GG in controlling acute watery diarrhea in Indian children: A randomized controlled trial. J Clin Gastroenterol. 2009;43(3): 208-213.
14. Misra S, Sabui TK, Pal NK. A randomized controlled trial to evaluate the efficacy of lactobacillus GG in infantile diarrhea. J Pediatr. 2009;155(1):129-132.
15. Arvola T, Laiho K, Torkkeli S, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: A randomized study. Pediatrics. 1999;104(5):e64.
16. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999; 135(5):564-568.
17. Armuzzi A, Cremonini F, Bartolozzi F, et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther. 2001;15(2):163-169.
18. Thomas MR, Litin SC, Osmon DR, Corr AP, Weaver AL, Lohse CM. Lack of effect of Lactobacillus GG on antibioticassociated diarrhea: A randomized, placebo-controlled trial. Mayo Clin Proc. 2001;76(9):883-889.
19. Szajewska H, Albrecht P, Topczewska-Cabanek A. Randomized, double-blind, placebo-controlled trial: Effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children. J Pediatr Gastroenterol Nutr. 2009;48(4):431-436.
20. Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: A blinded, randomized, controlled trial. Am J Respir Crit Care Med. 2010;182(8): 1058-1064.
21. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate. 2002;82(2): 103-108.
22. Billoo AG, Memon MA, Khaskheli SA, et al. Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea. World J Gastroenterol. 2006;12(28): 4557-4560.
23. Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study. Gastroenterology. 1989;96(4):981-988.
24. McFarland LV, Surawicz CM, Greenberg RN, et al. Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. Am J Gastroenterol. 1995; 90(3):439-448.
25. Lewis SJ, Potts LF, Barry RE. The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. J Infect. 1998;36(2):171-174.
26. Duman DG, Bor S, Ozü temiz O. Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacter pylori eradication. Eur J Gastroenterol Hepatol. 2005;17(12):1357-1361.
27. McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994;271(24):1913-1918.
28. Surawicz C, McFarland L, Greenberg R, et al. The search for a better treatment for recurrent Clostridium difficile disease: Use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis. 2000;31(4):1012-1017.
29. Gotz V, Romankiewicz JA, Moss J, Murray HW. Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm. 1979;36(6):754-757.
30. Tankanow RM, Ross MB, Ertel IJ, Dickinson DG, McCormick LS, Garfinkel JF. A double-blind, placebocontrolled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea. DICP. 1990;24(4):382-384.
31. Dubey AP, Rajeshwari K, Chakravarty A, Famularo G. Use of VSL#3 in the treatment of rotavirus diarrhea in children: Preliminary results. J Clin Gastroenterol. 2008;42(Suppl 3 Pt 1):S126-129.